Health Characteristics of Recreationally Active Female Cannabidiol Users: A Real-World Cross-Sectional Study

Why It Matters

The findings highlight a gap in sex‑specific evidence on CBD’s health impact and suggest that current marketing claims for recovery benefits lack support in active female populations.

Key Takeaways

• CBD users reported lower MET‑minutes than non‑users.
• Users slept less and reported poorer quality‑of‑life scores.
• Biomarker differences were modest and stayed within normal ranges.
• Most users took low doses (≈25 mg) of CBD.
• Study underscores lack of causal evidence for CBD recovery benefits.

Pulse Analysis

The U.S. cannabidiol market is projected to surpass $36 billion by 2033, driven by widespread claims that CBD aids muscle recovery, sleep and stress relief. Yet most clinical trials have focused on young men, leaving a knowledge vacuum for the growing segment of active women who increasingly turn to CBD supplements. This study provides one of the first real‑world snapshots of how recreationally active females use CBD, revealing typical dosing around 25 mg and a mix of oral, topical and inhaled products sourced from dispensaries and online retailers.

Behaviorally, the survey cohort showed that CBD users logged markedly fewer metabolic equivalent minutes, slept roughly 0.6 hours less per night, and scored lower on multiple quality‑of‑life dimensions compared with non‑users. Dietary quality was slightly better among users, but tobacco use was higher, suggesting a complex lifestyle profile. In the smaller biomarker subgroup, non‑users exhibited higher basophils, sex‑hormone‑binding globulin, testosterone and lower thyroid‑stimulating hormone, though all values remained within standard reference intervals. These physiological variations are modest and do not point to a clear therapeutic effect of typical low‑dose CBD regimens.

For industry stakeholders and health professionals, the study underscores the need for rigorously designed, sex‑specific longitudinal trials before endorsing CBD for performance or recovery. Consumers should be wary of low‑dose products that may not deliver the promised benefits and consider the broader lifestyle factors—such as sleep hygiene and tobacco use—that appear more strongly linked to the observed health outcomes. Future research that controls for dosage, formulation and co‑occurring behaviors will be essential to clarify CBD’s true role in the active female market.